Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Roflumilast

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 53,595Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcutis Presents Phase 2 Data on Infant Atopic Dermatitis at AAD
    Arcutis Presents Phase 2 Data on Infant Atopic Dermatitis at AAD

    28 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/28/3264182/0/en/Arcutis-Presents-New-Phase-2-Results-in-Infants-with-Atopic-Dermatitis-in-Late-Breaking-Session-Today-at-the-2026-American-Academy-of-Dermatology-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Mar 2026
    Share Share
    Arcutis To Unveil New Clinical Data At 2026 Aad Annual Meeting
    Arcutis To Unveil New Clinical Data At 2026 Aad Annual Meeting

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258097/0/en/Arcutis-to-Present-New-Clinical-Data-in-a-Late-Breaking-Podium-Presentation-and-Scientific-Posters-at-the-2026-American-Academy-of-Dermatology-Annual-Meeting.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Arcutis Publishes Positive Long-Term Data On ZORYVE Cream
    Arcutis Publishes Positive Long-Term Data On ZORYVE Cream

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252886/0/en/Arcutis-Announces-Publication-of-Positive-Long-Term-Safety-and-Efficacy-Data-with-ZORYVE-roflumilast-Cream-0-05-for-Treatment-of-Mild-to-Moderate-Atopic-Dermatitis-in-Children-Ages.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Arcutis Elevates Mas Matsuda To EVP & Chief Legal Officer
    Arcutis Elevates Mas Matsuda To EVP & Chief Legal Officer

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250243/0/en/Arcutis-Announces-Promotion-of-Mas-Matsuda-to-Executive-Vice-President-and-Chief-Legal-Officer-to-Support-Next-Phase-of-Growth.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Arcutis Unveils 2025 Financial Results And Business Update
    Arcutis Unveils 2025 Financial Results And Business Update

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244953/0/en/Arcutis-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Arcutis Reports Positive Phase 2 Results For ZORYVE Cream
    Arcutis Reports Positive Phase 2 Results For ZORYVE Cream

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230196/0/en/Arcutis-Announces-Positive-Topline-Results-for-INTEGUMENT-INFANT-Phase-2-Trial-of-ZORYVE-roflumilast-Cream-0-05-in-Infants-with-Mild-to-Moderate-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.